Caricamento...
Eligibility of sacubitril–valsartan in a real‐world heart failure population: a community‐based single‐centre study
AIMS: This study aims to investigate the eligibility of the Prospective Comparison of Angiotensin Receptor–Neprilysin Inhibitor (ARNI) with ACE inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM‐HF) study to a real‐world heart failure population. METHODS AND R...
Salvato in:
| Pubblicato in: | ESC Heart Fail |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880656/ https://ncbi.nlm.nih.gov/pubmed/29345425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12251 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|